OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 2

Data from combined, up to 2021-03-17.

Vaccinated at 2021-03-17 (%) Vaccinated at 2021-03-17 (n) Population Vaccinated at 2021-03-10 (%) Vaccinated in past week (%)
Overall - 26.1% 667,289 2,558,906 25.9% 0.2%
Sex Female 28.1% 416,143 1,481,970 27.9% 0.2%
Male 23.3% 251,146 1,076,936 23.2% 0.1%
Ethnicity White - British 25.7% 370,629 1,439,613 25.6% 0.1%
White - Irish 26.3% 5,502 20,923 26.1% 0.2%
White - Any other White background 24.9% 13,706 54,992 24.7% 0.2%
Mixed - White and Black Caribbean 31.4% 1,162 3,703 30.8% 0.6%
Mixed - White and Black African 22.2% 259 1,169 22.2% 0.0%
Mixed - White and Asian 25.0% 329 1,316 24.5% 0.5%
Mixed - Any other mixed background 26.2% 616 2,352 25.6% 0.6%
Asian or Asian British - Indian 24.6% 8,071 32,753 24.4% 0.3%
Asian or Asian British - Pakistani 33.9% 5,670 16,723 33.0% 0.9%
Asian or Asian British - Bangladeshi 35.6% 1,736 4,879 34.9% 0.7%
Asian or Asian British - Any other Asian background 25.4% 2,947 11,599 25.0% 0.4%
Black or Black British - Caribbean 32.1% 7,497 23,387 31.3% 0.7%
Black or Black British - African 27.2% 2,345 8,617 26.4% 0.8%
Black or Black British - Any other Black background 29.1% 728 2,506 28.2% 0.8%
Other ethnic groups - Chinese 24.3% 994 4,095 24.1% 0.2%
Other ethnic groups - Any other ethnic group 29.9% 2,044 6,832 29.4% 0.5%
Patients with any other ethnicity code 25.2% 99,799 395,654 25.1% 0.2%
Ethnicity not stated 29.2% 4,830 16,513 29.1% 0.2%
Ethnicity not recorded 27.1% 138,341 511,182 26.9% 0.2%
Ethnicity (broad categories) White 25.7% 389,858 1,515,535 25.6% 0.1%
Mixed 27.7% 2,373 8,554 27.3% 0.4%
South Asian 27.9% 18,438 65,975 27.5% 0.5%
Black 30.7% 10,584 34,517 29.9% 0.8%
Other 27.8% 3,045 10,934 27.5% 0.4%
Unknown 26.3% 242,977 923,363 26.1% 0.2%
Index of Multiple Deprivation 1 (most deprived) 29.5% 100,450 340,928 29.2% 0.3%
2 27.1% 117,558 433,622 26.9% 0.2%
3 26.2% 141,995 541,737 26.0% 0.2%
4 25.2% 148,603 588,546 25.1% 0.1%
5 (least deprived) 24.3% 153,853 634,340 24.1% 0.1%
Unknown 24.4% 4,802 19,691 24.2% 0.2%
Clinical Risk Groups Patients in Any Clinical Risk Group 27.0% 498,645 1,846,677 26.8% 0.2%
Patients with Immunosuppression 25.5% 28,280 110,999 25.3% 0.2%
Patients with CKD 27.6% 216,300 782,705 27.5% 0.2%
Patients who have Chronic Respiratory Disease 26.9% 82,572 306,810 26.7% 0.2%
Patients with Diabetes 27.4% 142,415 519,862 27.2% 0.2%
Patients with Chronic Liver disease 26.3% 12,285 46,746 26.1% 0.2%
Patients with CNS Disease (including Stroke/TIA) 31.5% 135,051 428,400 31.3% 0.2%
Patients with Chronic heart disease 27.3% 295,890 1,084,643 27.1% 0.2%
Patients with Asplenia or Dysfunction of the Spleen 24.7% 5,096 20,615 24.6% 0.1%
Patients with Wider Learning Disability 46.8% 609 1,302 46.2% 0.5%
Patients with Severe Mental Health 38.0% 6,608 17,409 37.6% 0.4%
Other Groups Patients who are shielding (High Risk from COVID-19) 30.3% 229,033 754,789 30.1% 0.2%
Patients with Morbid Obesity 34.9% 12,208 35,014 34.6% 0.3%
Patients who are pregnant 26.7% 84 315 26.7% 0.0%